AI will revolutionise drug discovery and healthcare: ARM CEO Rene Haas

Rene Haas, CEO of ARM Holdings, believes the biggest potential for artificial intelligence lies in healthcare. “Designing a chip versus curing cancer—I’m going to bet that the killer app for AI is in health,” he said, pointing to areas such as drug research, gene studies, genomics, and clinical trials.

Haas noted that AI can significantly accelerate the lengthy clinical trial process and drive innovation in drug discovery, helping combat diseases like cancer and Alzheimer’s.

Since the announcement of ARM’s Stargate AI technology in…